RATIONALE: Emphysema is characterized by destruction of alveoli with ensuing airspace enlargement and loss of alveoli. Induction of alveolar regeneration is still a major challenge in emphysema therapy. OBJECTIVES: To investigate whether therapeutic application of palifermin (DeltaN23-KGF) is able to induce a regenerative response in distal lung parenchyma after induction of pulmonary emphysema. METHODS: Mice were therapeutically treated at three occasions by oropharyngeal aspiration of 10 mg DeltaN23-KGF per kg body weight after induction of emphysema by porcine pancreatic elastase. MEASUREMENTS AND MAIN RESULTS: Airflow limitation associated with emphysema was largely reversed as assessed by noninvasive head-out body plethysmography. Porcine pancreatic elastase-induced airspace enlargement and loss of alveoli were partially reversed as assessed by design-based stereology. DeltaN23-KGF induced proliferation of epithelium, endothelium, and fibroblasts being associated with enhanced differentiation as well as increased expression of vascular endothelial growth factor, vascular endothelial growth factor receptors, transforming growth factor (TGF)-beta1, TGF-beta2, (phospho-) Smad2, plasminogen activator inhibitor-1, and elastin as assessed by quantitative reverse transcriptase-polymerase chain reaction, Western blotting, and immunohistochemistry. DeltaN23-KGF induced the expression of TGF-beta1 in and release of active TGF-beta1 from primary mouse alveolar epithelial type 2 (AE2) cells, murine AE2-like cells LA-4, and cocultures of LA-4 and murine lung fibroblasts (MLF), but not in MLF cultured alone. Recombinant TGF-beta1 but not DeltaN23-KGF induced elastin gene expression in MLF. Blockade of TGF-signaling by neutralizing antibody abolished these effects of DeltaN23-KGF in LA-4/MLF cocultures. CONCLUSIONS: Our data demonstrate that therapeutic application of DeltaN23-KGF has the potential to induce alveolar maintenance programs in emphysematous lungs and suggest that the regenerative effect on interstitial tissue is linked to AE2 cell-derived TGF-beta1.
RATIONALE: Emphysema is characterized by destruction of alveoli with ensuing airspace enlargement and loss of alveoli. Induction of alveolar regeneration is still a major challenge in emphysema therapy. OBJECTIVES: To investigate whether therapeutic application of palifermin (DeltaN23-KGF) is able to induce a regenerative response in distal lung parenchyma after induction of pulmonary emphysema. METHODS:Mice were therapeutically treated at three occasions by oropharyngeal aspiration of 10 mg DeltaN23-KGF per kg body weight after induction of emphysema by porcine pancreatic elastase. MEASUREMENTS AND MAIN RESULTS: Airflow limitation associated with emphysema was largely reversed as assessed by noninvasive head-out body plethysmography. Porcine pancreatic elastase-induced airspace enlargement and loss of alveoli were partially reversed as assessed by design-based stereology. DeltaN23-KGF induced proliferation of epithelium, endothelium, and fibroblasts being associated with enhanced differentiation as well as increased expression of vascular endothelial growth factor, vascular endothelial growth factor receptors, transforming growth factor (TGF)-beta1, TGF-beta2, (phospho-) Smad2, plasminogen activator inhibitor-1, and elastin as assessed by quantitative reverse transcriptase-polymerase chain reaction, Western blotting, and immunohistochemistry. DeltaN23-KGF induced the expression of TGF-beta1 in and release of active TGF-beta1 from primary mousealveolar epithelial type 2 (AE2) cells, murineAE2-like cells LA-4, and cocultures of LA-4 and murine lung fibroblasts (MLF), but not in MLF cultured alone. Recombinant TGF-beta1 but not DeltaN23-KGF induced elastin gene expression in MLF. Blockade of TGF-signaling by neutralizing antibody abolished these effects of DeltaN23-KGF in LA-4/MLF cocultures. CONCLUSIONS: Our data demonstrate that therapeutic application of DeltaN23-KGF has the potential to induce alveolar maintenance programs in emphysematous lungs and suggest that the regenerative effect on interstitial tissue is linked to AE2 cell-derived TGF-beta1.
Authors: Tuong-Van Hoang; Claudio Nardiello; David E Surate Solaligue; José Alberto Rodríguez-Castillo; Philipp Rath; Konstantin Mayer; István Vadász; Susanne Herold; Kathrin Ahlbrecht; Werner Seeger; Rory E Morty Journal: J Anat Date: 2018-01-09 Impact factor: 2.610
Authors: A H E Herbers; W J F M van der Velden; A F J de Haan; J P Donnelly; N M A Blijlevens Journal: Bone Marrow Transplant Date: 2013-08-19 Impact factor: 5.483
Authors: Rim S J Sarker; Gerrit John-Schuster; Alexander Bohla; Kathrin Mutze; Gerald Burgstaller; Mark T Bedford; Melanie Königshoff; Oliver Eickelberg; Ali Ö Yildirim Journal: Am J Respir Cell Mol Biol Date: 2015-12 Impact factor: 6.914
Authors: Changyu Zheng; Ana P Cotrim; Anne Rowzee; William Swaim; Anastasia Sowers; James B Mitchell; Bruce J Baum Journal: Clin Cancer Res Date: 2011-03-02 Impact factor: 12.531
Authors: Mark V Avdalovic; Nancy K Tyler; Lei Putney; Susie J Nishio; Sherri Quesenberry; Parmjit J Singh; Lisa A Miller; Edward S Schelegle; Charles G Plopper; Thiennu Vu; Dallas M Hyde Journal: Anat Rec (Hoboken) Date: 2012-08-13 Impact factor: 2.064
Authors: Felix G Meinel; Felix Schwab; Simone Schleede; Martin Bech; Julia Herzen; Klaus Achterhold; Sigrid Auweter; Fabian Bamberg; Ali Ö Yildirim; Alexander Bohla; Oliver Eickelberg; Rod Loewen; Martin Gifford; Ronald Ruth; Maximilian F Reiser; Franz Pfeiffer; Konstantin Nikolaou Journal: PLoS One Date: 2013-03-26 Impact factor: 3.240